BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 8799169)

  • 1. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
    Wasik MA; Nowak I; Zhang Q; Shaw LM
    Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
    Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
    Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
    Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
    Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway.
    Wang H; Xie X; Lu WG; Ye DF; Chen HZ; Li X; Cheng Q
    Life Sci; 2004 Feb; 74(14):1739-49. PubMed ID: 14741732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
    Campbell JD; Cook G; Robertson SE; Fraser A; Boyd KS; Gracie JA; Franklin IM
    J Immunol; 2001 Jul; 167(1):553-61. PubMed ID: 11418694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
    Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
    Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J; Zhang D; Zhou C; Marasco WA
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
    Liu J; Kern JA
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
    Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K
    J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M; Meng C; Ivashkiv LB
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.